Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 18, 2018 Filed Jan 22, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-18-004725 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,424 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $10.09 | $100,882.00 |
DisclosureSEC source: 0001209191-18-004725 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 512,143 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-18-004725 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 522,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:10 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-18-002913 · doc4.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 19,394 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:10 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $10.08 | $100,769.00 |
DisclosureSEC source: 0001209191-18-002913 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 713,510 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.96 to $10.29, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:10 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-18-002913 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 723,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-18-002907 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,394 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $10.08 | $100,769.00 |
DisclosureSEC source: 0001209191-18-002907 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,510 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.96 to $10.29, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:08 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-18-002907 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:19 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-066638 · doc4.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,424 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:19 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $9.16 | $91,553.00 |
DisclosureSEC source: 0001209191-17-066638 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,143 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.0501 to $9.3500, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:19 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-17-066638 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:21 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-066639 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 32,424 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:21 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $9.16 | $91,553.00 |
DisclosureSEC source: 0001209191-17-066639 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 512,143 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.0501 to $9.3500, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:21 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-17-066639 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 522,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:04 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $6.54 | $0.00 |
DisclosureSEC source: 0001209191-17-065406 · doc4.xml · derivative · entry 5 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 17,000 shares Expires 2026-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:04 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 644 | $9.59 | $6,172.93 |
DisclosureSEC source: 0001209191-17-065406 · doc4.xml · nonDerivative · entry 4 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,381 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at $9.56 and $9.59. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:04 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 16,356 | $9.93 | $162,442.89 |
DisclosureSEC source: 0001209191-17-065406 · doc4.xml · nonDerivative · entry 3 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,025 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.60 to $10.59, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:04 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
Exercise / conversionCommon Stock | 17,000 | $6.54 | $111,180.00 |
DisclosureSEC source: 0001209191-17-065406 · doc4.xml · nonDerivative · entry 2 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:04 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 10,042 | $10.88 | $109,255.96 |
DisclosureSEC source: 0001209191-17-065406 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,381 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.68 to $11.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-064687 · doc4.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 29,394 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $10.39 | $103,903.00 |
DisclosureSEC source: 0001209191-17-064687 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 713,510 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-17-064687 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 723,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F2 · balance_after: Reflects the contribution of 60,000 shares previously owned directly by the spouse of the reporting person to the Sharon Shacham 2016 Qualified Annuity Interest Trust ("Spouse's GRAT") on September 9, 2016 and the transfer of 12,691 shares from the Spouse's GRAT to the spouse of the reporting person on November 6, 2017. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-064683 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,394 Underlying: Common Stock · 10,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $10.39 | $103,903.00 |
DisclosureSEC source: 0001209191-17-064683 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,510 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $0.26 | $2,640.00 |
DisclosureSEC source: 0001209191-17-064683 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Reflects the contribution of 60,000 shares previously owned directly to the Sharon Shacham 2016 Qualified Annuity Interest Trust ("GRAT") on September 9, 2016 and the transfer of 12,691 shares from the GRAT to the reporting person on November 6, 2017. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:04 UTC |
Frenkel RanChief Dev Operations Officer
|
SaleCommon Stock | 4,958 | $11.25 | $55,755.19 |
DisclosureSEC source: 0001209191-17-059945 · doc4.xml · nonDerivative · entry 1 Frenkel Ran · CIK 0001623108 · Chief Dev Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,733 F1 · kind: This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 6, 2017 and November 7, 2017 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:03 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 4,958 | $11.25 | $55,755.19 |
DisclosureSEC source: 0001209191-17-059944 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,423 F1 · kind: This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 6, 2017 and November 7, 2017 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| November 05, 2017 Filed Nov 6, 2017 21:09 UTC |
Frenkel RanChief Dev Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059399 · doc4.xml · derivative · entry 2 Frenkel Ran · CIK 0001623108 · Chief Dev Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. F2 · derivative.exercise_date: On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016. The remaining 50% of the restricted stock units vested on November 5, 2017. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. F2 · derivative.expiration_date: On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016. The remaining 50% of the restricted stock units vested on November 5, 2017. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. Read SEC document |
| November 05, 2017 Filed Nov 6, 2017 21:09 UTC |
Frenkel RanChief Dev Operations Officer
|
Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-059399 · doc4.xml · nonDerivative · entry 1 Frenkel Ran · CIK 0001623108 · Chief Dev Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. Read SEC document |
| November 05, 2017 Filed Nov 6, 2017 21:05 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059396 · doc4.xml · derivative · entry 2 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. F2 · derivative.exercise_date: On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016. The remaining 50% of the restricted stock units vested on November 5, 2017. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. F2 · derivative.expiration_date: On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016. The remaining 50% of the restricted stock units vested on November 5, 2017. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. Read SEC document |
| November 05, 2017 Filed Nov 6, 2017 21:05 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-059396 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:08 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-055754 · doc4.xml · derivative · entry 3 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099 Underlying: Common Stock · 2,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:08 UTC |
Mirza Mansoor RazaDirector
|
SaleCommon Stock | 2,000 | $12.00 | $24,000.00 |
DisclosureSEC source: 0001209191-17-055754 · doc4.xml · nonDerivative · entry 2 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:08 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionCommon Stock | 2,000 | $0.26 | $528.00 |
DisclosureSEC source: 0001209191-17-055754 · doc4.xml · nonDerivative · entry 1 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:06 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 1,500 | $12.00 | $18,000.00 |
DisclosureSEC source: 0001209191-17-055750 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,381 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:11 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,882 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-053151 · doc4.xml · derivative · entry 3 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,099 Underlying: Common Stock · 2,882 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:11 UTC |
Mirza Mansoor RazaDirector
|
SaleCommon Stock | 2,882 | $11.00 | $31,702.00 |
DisclosureSEC source: 0001209191-17-053151 · doc4.xml · nonDerivative · entry 2 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:11 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionCommon Stock | 2,882 | $0.26 | $760.85 |
DisclosureSEC source: 0001209191-17-053151 · doc4.xml · nonDerivative · entry 1 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:09 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 2,000 | $11.00 | $22,000.00 |
DisclosureSEC source: 0001209191-17-053148 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,881 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 16:09 UTC |
FALVEY MICHAELEVP, CFO & Treasurer
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001209191-17-052585 · doc4.xml · derivative · entry 1 FALVEY MICHAEL · CIK 0001286197 · EVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-09-10 F1 · derivative.exercise_date: This option was granted on September 11, 2017. The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 20:13 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 118 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001209191-17-052587 · doc4.xml · derivative · entry 3 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,981 Underlying: Common Stock · 118 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 12, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 20:13 UTC |
Mirza Mansoor RazaDirector
|
SaleCommon Stock | 118 | $11.00 | $1,298.00 |
DisclosureSEC source: 0001209191-17-052587 · doc4.xml · nonDerivative · entry 2 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 20:13 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionCommon Stock | 118 | $0.26 | $31.15 |
DisclosureSEC source: 0001209191-17-052587 · doc4.xml · nonDerivative · entry 1 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 20:09 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 2,195 | $10.00 | $21,950.00 |
DisclosureSEC source: 0001209191-17-050698 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,686 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 2,062 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan. Read SEC document |
| June 26, 2017 Filed Sep 1, 2017 21:43 UTC |
Primiano Christopher BrettSVP, OPS, BUS DEV, GC & SEC
|
SaleCommon Stock | 805 | $10.03 | $8,071.01 |
DisclosureSEC source: 0001209191-17-051076 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · SVP, OPS, BUS DEV, GC & SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,881 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in transactions at $10.00 and $10.07. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. F3 · balance_after: Amount also reflects the number of shares sold by the reporting person as previously reported on the Form 4 filed on August 30, 2017 (the "Previous Form 4") as well as the acquisition of 2,062 shares under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan, which was previously disclosed on the Previous Form 4. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:41 UTC |
Dolsten MikaelDirector
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-17-040539 · doc4.xml · derivative · entry 1 Dolsten Mikael · CIK 0001437590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2027-06-14 F1 · derivative.exercise_date: This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:47 UTC |
Greene Barry EDirector
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-17-040558 · doc4.xml · derivative · entry 1 Greene Barry E · CIK 0001291963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2027-06-14 F1 · derivative.exercise_date: This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:50 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-17-040570 · doc4.xml · derivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2027-06-14 F1 · derivative.exercise_date: This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 16:52 UTC |
WEG KENNETH EDirector
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001209191-17-040574 · doc4.xml · derivative · entry 1 WEG KENNETH E · CIK 0001192596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2027-06-14 F1 · derivative.exercise_date: This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.